Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02960386 · ClinicalTrials.gov registry record · NA

An Engagement Engine for Fitness Trackers

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
184
Enrollment target

NCT02960386: Completed NA study, sponsored by Massachusetts General Hospital.

NCT02960386 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 184 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02960386, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
184 participants
Enrollment target

Study Summary

The iTrackFitness study aims to test the "engagement engine" that was developed from activity tracker and survey data gathered during phase I of the study. For the current phase the "engagement engine" will support successful and sustained engagement with health trackers thereby increasing physical activity.

Primary Outcome

To assess the level of participant's engagement with physical activity tracker

Interventions

  • OTHER Machine Learning Algorithm

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2016-01
Est. Completion 2020-07
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT02960386 record still lists

NCT02960386 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 1 intervention - of which Machine Learning Algorithm is the first listed.

NCT02960386 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02960386 about?

NCT02960386 is a clinical study titled "An Engagement Engine for Fitness Trackers". The iTrackFitness study aims to test the "engagement engine" that was developed from activity tracker and survey data gathered during phase I of the study. For the current phase the "engagement engine" will support successful and sustained engagement with health trackers thereby increasing physical ...

What is the current status of trial NCT02960386?

This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2016-01. Estimated completion is 2020-07.

What interventions are being tested in trial NCT02960386?

The interventions under investigation include: Machine Learning Algorithm (OTHER).

Who is sponsoring clinical trial NCT02960386?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02960386's enrollment target sits among peer trials

184 581st of 2000 higher than 1,417 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03903510 · 184 participants · NA

    Virtual Reality During Pediatric Cast Removal

  • NCT04020510 · 184 participants · Phase 4

    Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder

  • NCT04135846 · 184 participants · Phase 2

    Alpha-1 Blockade for Alcohol Use Disorder (AUD)

  • NCT04396873 · 184 participants · Phase 1

    PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02960386, the US trial registry maintained by the National Library of Medicine. NCT02960386 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.